NFKB1 and chronic obstructive pulmonary disease: IMD-1041, a prodrug of IMD-0354, is another IKKβ inhibitor that has been shown to alleviate NF-κB-mediated cardiac dysfunction, kidney injury, and COPD [434, 435].